Pharming Market Cap from 2010 to 2026
| PHARM Stock | EUR 1.44 0.04 2.86% |
Market Cap | First Reported 2010-12-31 | Previous Quarter 573.7 M | Current Value 296.6 M | Quarterly Volatility 387.1 M |
Check Pharming Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharming Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 12.3 M, Interest Expense of 6.6 M or Selling And Marketing Expenses of 7.8 M, as well as many indicators such as Price To Sales Ratio of 2.43, Dividend Yield of 0.0 or PTB Ratio of 3.82. Pharming financial statements analysis is a perfect complement when working with Pharming Group Valuation or Volatility modules.
Pharming | Market Cap |
Analyzing Pharming Group's Market Cap over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Market Cap has evolved provides context for assessing Pharming Group's current valuation and future prospects.
Latest Pharming Group's Market Cap Growth Pattern
Below is the plot of the Market Cap of Pharming Group NV over the last few years. It is Pharming Group's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharming Group's overall financial position and show how it may be relating to other accounts over time.
| Market Cap | 10 Years Trend |
|
Market Cap |
| Timeline |
Pharming Market Cap Regression Statistics
| Arithmetic Mean | 516,451,003 | |
| Geometric Mean | 311,284,802 | |
| Coefficient Of Variation | 74.96 | |
| Mean Deviation | 338,720,389 | |
| Median | 573,748,588 | |
| Standard Deviation | 387,146,471 | |
| Sample Variance | 149882.4T | |
| Range | 1.1B | |
| R-Value | 0.59 | |
| Mean Square Error | 104788.8T | |
| R-Squared | 0.34 | |
| Significance | 0.01 | |
| Slope | 45,002,341 | |
| Total Sum of Squares | 2398118.2T |
Pharming Market Cap History
About Pharming Group Financial Statements
Pharming Group stakeholders use historical fundamental indicators, such as Pharming Group's Market Cap, to determine how well the company is positioned to perform in the future. Although Pharming Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pharming Group's assets and liabilities are reflected in the revenues and expenses on Pharming Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pharming Group NV. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Market Cap | 573.7 M | 296.6 M |
Thematic Opportunities
Explore Investment Opportunities
Check out the analysis of Pharming Group Correlation against competitors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.